SG11201810544WA - Detecting hematological disorders using cell-free dna in blood - Google Patents
Detecting hematological disorders using cell-free dna in bloodInfo
- Publication number
- SG11201810544WA SG11201810544WA SG11201810544WA SG11201810544WA SG11201810544WA SG 11201810544W A SG11201810544W A SG 11201810544WA SG 11201810544W A SG11201810544W A SG 11201810544WA SG 11201810544W A SG11201810544W A SG 11201810544WA SG 11201810544W A SG11201810544W A SG 11201810544WA
- Authority
- SG
- Singapore
- Prior art keywords
- cell
- international
- hong kong
- shatin
- hematological
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 title abstract 4
- 239000008280 blood Substances 0.000 title abstract 4
- 208000014951 hematologic disease Diseases 0.000 title abstract 3
- 230000002489 hematologic effect Effects 0.000 abstract 3
- 238000003556 assay Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000011987 methylation Effects 0.000 abstract 2
- 238000007069 methylation reaction Methods 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000003924 normoblast Anatomy 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662343050P | 2016-05-30 | 2016-05-30 | |
PCT/CN2017/086509 WO2017206888A1 (en) | 2016-05-30 | 2017-05-30 | Detecting hematological disorders using cell-free dna in blood |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201810544WA true SG11201810544WA (en) | 2018-12-28 |
Family
ID=60479040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201810544WA SG11201810544WA (en) | 2016-05-30 | 2017-05-30 | Detecting hematological disorders using cell-free dna in blood |
Country Status (12)
Country | Link |
---|---|
US (3) | US10781490B2 (ja) |
EP (3) | EP3464637B1 (ja) |
JP (3) | JP6987393B2 (ja) |
KR (3) | KR102605504B1 (ja) |
CN (2) | CN109196120B (ja) |
AU (2) | AU2017274038B2 (ja) |
CA (1) | CA3025708A1 (ja) |
DK (2) | DK3464637T3 (ja) |
IL (2) | IL303115A (ja) |
SG (1) | SG11201810544WA (ja) |
TW (1) | TWI838330B (ja) |
WO (1) | WO2017206888A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3889272A1 (en) | 2014-07-18 | 2021-10-06 | The Chinese University of Hong Kong | Methylation pattern analysis of tissues in dna mixture |
US10781490B2 (en) | 2016-05-30 | 2020-09-22 | The Chinese University Of Hong Kong | Detecting hematological disorders using cell-free DNA in blood |
JP2020503003A (ja) | 2016-11-30 | 2020-01-30 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 尿および他のサンプルにおける無細胞dnaの分析 |
SG11201906397UA (en) | 2017-01-25 | 2019-08-27 | Univ Hong Kong Chinese | Diagnostic applications using nucleic acid fragments |
ES2959360T3 (es) | 2017-07-26 | 2024-02-23 | Univ Hong Kong Chinese | Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares |
US12089930B2 (en) | 2018-03-05 | 2024-09-17 | Marquette University | Method and apparatus for non-invasive hemoglobin level prediction |
EP3947717A4 (en) | 2019-03-25 | 2022-12-28 | The Chinese University Of Hong Kong | DETERMINATION OF LINEAR AND ROUND SHAPES OF CIRCULATION NUCLEIC ACIDS |
CN110361531B (zh) * | 2019-08-02 | 2023-04-11 | 天津医科大学总医院 | 一种检测微粒促凝活性的实验方法 |
WO2021127526A1 (en) * | 2019-12-20 | 2021-06-24 | William Marsh Rice University | Methods for extracting and sequencing single-stranded dna and rna from non-treated biospecimens |
CN111518876B (zh) * | 2020-05-11 | 2023-01-13 | 润方(北京)生物医药研究院有限公司 | 一种牛血红蛋白制品中牛源基因组dna定量检测方法及其应用 |
KR102517894B1 (ko) * | 2021-02-23 | 2023-04-04 | 연세대학교 산학협력단 | 당뇨발에 의한 하지 절단 수술의 치료 반응성을 예측하는 방법 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2253461T3 (es) | 2002-03-05 | 2006-06-01 | Epigenomics Ag | Procedimiento y dispositivo para la determinacion de la especificidad del tejido y del adn que flota libre en tejidos corporales. |
US20090176655A1 (en) * | 2007-11-16 | 2009-07-09 | Oncomethylome Sciences Sa | Methylation detection |
US20110028333A1 (en) * | 2009-05-01 | 2011-02-03 | Brown University | Diagnosing, prognosing, and early detection of cancers by dna methylation profiling |
DK2529032T3 (en) | 2010-01-26 | 2017-05-01 | Nipd Genetics Ltd | METHODS AND COMPOSITIONS FOR NON-INVASIVE PRE-NATIONAL DIAGNOSTICATION OF Fetal ANEUPLOIDITIES |
EP2558854B1 (en) | 2010-04-16 | 2018-10-10 | Chronix Biomedical | Breast cancer associated circulating nucleic acid biomarkers |
AU2011335891B2 (en) | 2010-11-30 | 2015-03-26 | The Chinese University Of Hong Kong | Detection of genetic or molecular aberrations associated with cancer |
WO2012103031A2 (en) | 2011-01-25 | 2012-08-02 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
US20140178348A1 (en) | 2011-05-25 | 2014-06-26 | The Regents Of The University Of California | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
CN113388605A (zh) | 2011-09-26 | 2021-09-14 | 凯杰有限公司 | 用于分离细胞外核酸的快速方法 |
CA2852098C (en) | 2011-10-21 | 2023-05-02 | Chronix Biomedical | Colorectal cancer associated circulating nucleic acid biomarkers |
US9732390B2 (en) * | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
PT2898100T (pt) * | 2012-09-20 | 2018-02-26 | Univ Hong Kong Chinese | Determinação não invasiva de um metiloma de feto ou tumor a partir de plasma |
EP3099822A4 (en) | 2014-01-30 | 2017-08-30 | The Regents of the University of California | Methylation haplotyping for non-invasive diagnosis (monod) |
HRP20240189T1 (hr) | 2014-04-14 | 2024-04-26 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Postupak i komplet za utvrđivanje odumiranja stanica ili tkiva ili tkivnog ili staničnog podrijetla dnk-a analizom metilacije dnk-a |
MA39951A (fr) | 2014-05-09 | 2017-03-15 | Lifecodexx Ag | Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées |
EP3889272A1 (en) | 2014-07-18 | 2021-10-06 | The Chinese University of Hong Kong | Methylation pattern analysis of tissues in dna mixture |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
US10781490B2 (en) | 2016-05-30 | 2020-09-22 | The Chinese University Of Hong Kong | Detecting hematological disorders using cell-free DNA in blood |
-
2017
- 2017-05-30 US US15/608,863 patent/US10781490B2/en active Active
- 2017-05-30 KR KR1020227044979A patent/KR102605504B1/ko active IP Right Grant
- 2017-05-30 EP EP17805833.5A patent/EP3464637B1/en active Active
- 2017-05-30 CN CN201780033380.0A patent/CN109196120B/zh active Active
- 2017-05-30 IL IL303115A patent/IL303115A/en unknown
- 2017-05-30 EP EP23214529.2A patent/EP4324937A3/en active Pending
- 2017-05-30 EP EP21163406.8A patent/EP3885447B1/en active Active
- 2017-05-30 CA CA3025708A patent/CA3025708A1/en active Pending
- 2017-05-30 KR KR1020237039843A patent/KR20230164209A/ko active Application Filing
- 2017-05-30 JP JP2018562945A patent/JP6987393B2/ja active Active
- 2017-05-30 AU AU2017274038A patent/AU2017274038B2/en active Active
- 2017-05-30 IL IL262953A patent/IL262953B2/en unknown
- 2017-05-30 DK DK17805833.5T patent/DK3464637T3/da active
- 2017-05-30 DK DK21163406.8T patent/DK3885447T3/da active
- 2017-05-30 KR KR1020187037241A patent/KR102482616B1/ko active IP Right Grant
- 2017-05-30 WO PCT/CN2017/086509 patent/WO2017206888A1/en unknown
- 2017-05-30 SG SG11201810544WA patent/SG11201810544WA/en unknown
- 2017-05-30 CN CN202210823171.9A patent/CN115161390A/zh active Pending
- 2017-05-31 TW TW106117990A patent/TWI838330B/zh active
-
2020
- 2020-08-19 US US16/997,435 patent/US11873527B2/en active Active
-
2021
- 2021-11-24 JP JP2021189986A patent/JP7537758B2/ja active Active
-
2023
- 2023-05-26 AU AU2023203305A patent/AU2023203305A1/en active Pending
- 2023-12-14 US US18/540,667 patent/US20240229103A1/en active Pending
-
2024
- 2024-02-13 JP JP2024019464A patent/JP2024054311A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201810544WA (en) | Detecting hematological disorders using cell-free dna in blood | |
SG11201903346QA (en) | Gestational age assessment by methylation and size profiling of maternal plasma dna | |
SG11201906397UA (en) | Diagnostic applications using nucleic acid fragments | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
SG11201903928WA (en) | Mesenchymal stem cells populations, their products, and use thereof | |
SG11201908396PA (en) | Methods of treating tumor | |
SG11201809874SA (en) | Systems and methods for locating a wireless device | |
SG11201903480TA (en) | Cell culture device system and methods of use thereof | |
SG11201804360XA (en) | Mat2a inhibitors for treating mtap null cancer | |
SG11201809606YA (en) | Combination therapy for cancer treatment | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201909501TA (en) | Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro | |
SG11201811408PA (en) | Adoptive cell transfer and oncolytic virus combination therapy | |
SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
SG11201807041PA (en) | Improved preparations of adult liver progenitor cells | |
SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
SG11201810333UA (en) | Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disorders | |
SG11201804784RA (en) | Wide speed range concrete monitoring calibration | |
SG11201804440XA (en) | Chemical reprogramming of human glial cells into neurons with small molecule cocktail | |
SG11201900408RA (en) | Topical formulation for promoting wound healing | |
SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
SG11201806946VA (en) | Epigenomic profiling reveals the somatic promoter landscape of primary gastric adenocarcinoma | |
SG11201900043TA (en) | Antibody formulations | |
SG11201806945SA (en) | Cancer epigenetic profiling |